Yale School of Medicine Dept.of Ob/Gyn & Reproductive Sciences
Welcome,         Profile    Billing    Logout  
 14 Trials 
22 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Taylor, Hugh
KEEPS, NCT00623311: Cognitive and Affective Study

Active, not recruiting
4
720
US
oral conjugated equine estrogens, transdermal estradiol, micronized progesterone, Placebo
University of Wisconsin, Madison, Kronos Longevity Research Institute, University of Utah, University of California, Albert Einstein College of Medicine of Yeshiva University, Brigham and Women's Hospital, Columbia University, Mayo Clinic, University of Washington, Yale University
Perimenopause, Coronary Disease, Estrogen Replacement Therapy, Hormone Replacement Therapy
04/12
04/12
PREGnant, NCT06375811: Pre-IVF Treatment With a GnRH Antagonist in Women With endometriosis_temp

Recruiting
3
288
US
Elagolix 200 MG, Orlissa, Placebo or SOC IVF
Yale University, University of Colorado, Denver, Northwestern University, University of North Carolina, Duke University, Johns Hopkins University
Infertility, Endometriosis
06/26
06/26
NCT04173169: Pre-IVF Treatment With a GnRH Antagonist in Women With Endometriosis

Active, not recruiting
3
112
US
Elagolix 200 MG, Orlissa, Placebo or SOC IVF
Yale University, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), University of Colorado, Denver, Northwestern University, University of North Carolina
Infertility, Endometriosis
05/25
05/25
FRIEND, NCT05364008: Fibroids and Unexplained Infertility Treatment With Epigallocatechin Gallate; A Natural CompounD in Green Tea

Recruiting
3
50
US
Green Tea Extract, EGCG (epigallocatechin gallate), Placebo
Yale University, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), University of Chicago, University of Illinois at Chicago, Johns Hopkins University
Leiomyoma, Uterine
12/25
12/25
ELENA, NCT05560646: A Study to Investigate Efficacy and Safety of OG-6219 BID in 3 Dose Levels Compared With Placebo in Participants Aged 18 to 49 With Moderate to Severe Endometriosis-related Pain

Active, not recruiting
2
380
Europe, US, RoW
OG-6219, Placebo
Organon and Co, Iqvia Pty Ltd
Endometriosis
05/25
05/25
NCT05343572: Bone Marrow Derived Stem Cells Mobilization for Treatment of Abnormal Endometrium

Recruiting
1
30
US
Plerixafor
Hugh Taylor
Asherman Syndrome, Atrophic Endometrium, Recurrent Implantation Failure
12/25
12/26
GPRPL, NCT05444283: Genomic Predictors of Recurrent Pregnancy Loss

Recruiting
N/A
1000
US
Yale University, Johns Hopkins University, University of Texas at Austin, Penn State University, Northwestern University, The University of Texas Health Science Center at San Antonio, Wayne State University, Columbia University, University of Colorado, Denver, University of Oklahoma, University of Chicago, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Recurrent Pregnancy Loss
12/26
12/26
NCT03756480: Cancer Driving Mutations in Endometriosis Lesions and Development of Progesterone Resistance

Recruiting
N/A
135
US
Johns Hopkins University, National Institutes of Health (NIH), Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Endometriosis, Endometrial Diseases
10/26
10/26
Santoro, Nanette
KEEPS, NCT00623311: Cognitive and Affective Study

Active, not recruiting
4
720
US
oral conjugated equine estrogens, transdermal estradiol, micronized progesterone, Placebo
University of Wisconsin, Madison, Kronos Longevity Research Institute, University of Utah, University of California, Albert Einstein College of Medicine of Yeshiva University, Brigham and Women's Hospital, Columbia University, Mayo Clinic, University of Washington, Yale University
Perimenopause, Coronary Disease, Estrogen Replacement Therapy, Hormone Replacement Therapy
04/12
04/12
PREGnant, NCT06375811: Pre-IVF Treatment With a GnRH Antagonist in Women With endometriosis_temp

Recruiting
3
288
US
Elagolix 200 MG, Orlissa, Placebo or SOC IVF
Yale University, University of Colorado, Denver, Northwestern University, University of North Carolina, Duke University, Johns Hopkins University
Infertility, Endometriosis
06/26
06/26
NCT04173169: Pre-IVF Treatment With a GnRH Antagonist in Women With Endometriosis

Active, not recruiting
3
112
US
Elagolix 200 MG, Orlissa, Placebo or SOC IVF
Yale University, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), University of Colorado, Denver, Northwestern University, University of North Carolina
Infertility, Endometriosis
05/25
05/25
NCT06686537: Convergent Mechanisms Underlying Reprometabolic Syndrome in Women

Not yet recruiting
2
20
US
Estradiol Patches
University of Colorado, Denver, Colorado Clinical & Translational Sciences Institute
Infertility, Female, Obesity
10/26
12/26
NCT06414096: Use of Pulsatile Intravenous FSH to Mitigate Reprometabolic Syndrome

Recruiting
1
5
US
Follicle Stimulating Hormone, FSH
University of Colorado, Denver
Infertility, Obesity
11/25
11/26
GPRPL, NCT05444283: Genomic Predictors of Recurrent Pregnancy Loss

Recruiting
N/A
1000
US
Yale University, Johns Hopkins University, University of Texas at Austin, Penn State University, Northwestern University, The University of Texas Health Science Center at San Antonio, Wayne State University, Columbia University, University of Colorado, Denver, University of Oklahoma, University of Chicago, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Recurrent Pregnancy Loss
12/26
12/26
Frank, Michele
PREGnant, NCT06375811: Pre-IVF Treatment With a GnRH Antagonist in Women With endometriosis_temp

Recruiting
3
288
US
Elagolix 200 MG, Orlissa, Placebo or SOC IVF
Yale University, University of Colorado, Denver, Northwestern University, University of North Carolina, Duke University, Johns Hopkins University
Infertility, Endometriosis
06/26
06/26
NCT04173169: Pre-IVF Treatment With a GnRH Antagonist in Women With Endometriosis

Active, not recruiting
3
112
US
Elagolix 200 MG, Orlissa, Placebo or SOC IVF
Yale University, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), University of Colorado, Denver, Northwestern University, University of North Carolina
Infertility, Endometriosis
05/25
05/25
Coraluzzi, Luisa
NCT03756480: Cancer Driving Mutations in Endometriosis Lesions and Development of Progesterone Resistance

Recruiting
N/A
135
US
Johns Hopkins University, National Institutes of Health (NIH), Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Endometriosis, Endometrial Diseases
10/26
10/26
Taylor, Hugn
PREGnant, NCT06375811: Pre-IVF Treatment With a GnRH Antagonist in Women With endometriosis_temp

Recruiting
3
288
US
Elagolix 200 MG, Orlissa, Placebo or SOC IVF
Yale University, University of Colorado, Denver, Northwestern University, University of North Carolina, Duke University, Johns Hopkins University
Infertility, Endometriosis
06/26
06/26
NCT04173169: Pre-IVF Treatment With a GnRH Antagonist in Women With Endometriosis

Active, not recruiting
3
112
US
Elagolix 200 MG, Orlissa, Placebo or SOC IVF
Yale University, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), University of Colorado, Denver, Northwestern University, University of North Carolina
Infertility, Endometriosis
05/25
05/25
Schepisi, Lisa
FRIEND, NCT05364008: Fibroids and Unexplained Infertility Treatment With Epigallocatechin Gallate; A Natural CompounD in Green Tea

Recruiting
3
50
US
Green Tea Extract, EGCG (epigallocatechin gallate), Placebo
Yale University, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), University of Chicago, University of Illinois at Chicago, Johns Hopkins University
Leiomyoma, Uterine
12/25
12/25
ELENA, NCT05560646: A Study to Investigate Efficacy and Safety of OG-6219 BID in 3 Dose Levels Compared With Placebo in Participants Aged 18 to 49 With Moderate to Severe Endometriosis-related Pain

Active, not recruiting
2
380
Europe, US, RoW
OG-6219, Placebo
Organon and Co, Iqvia Pty Ltd
Endometriosis
05/25
05/25
Tepede, Abisola
NCT04173169: Pre-IVF Treatment With a GnRH Antagonist in Women With Endometriosis

Active, not recruiting
3
112
US
Elagolix 200 MG, Orlissa, Placebo or SOC IVF
Yale University, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), University of Colorado, Denver, Northwestern University, University of North Carolina
Infertility, Endometriosis
05/25
05/25

Download Options